NOCERA, LUIGI
 Distribuzione geografica
Continente #
EU - Europa 1.005
AS - Asia 703
NA - Nord America 690
SA - Sud America 174
AF - Africa 19
AN - Antartide 1
OC - Oceania 1
Totale 2.593
Nazione #
US - Stati Uniti d'America 655
RU - Federazione Russa 651
SG - Singapore 233
CN - Cina 216
BR - Brasile 136
SE - Svezia 115
VN - Vietnam 93
HK - Hong Kong 74
IT - Italia 55
FR - Francia 39
DE - Germania 38
CA - Canada 25
GB - Regno Unito 22
IN - India 21
FI - Finlandia 18
PL - Polonia 18
AR - Argentina 15
ES - Italia 13
NL - Olanda 10
ZA - Sudafrica 10
BD - Bangladesh 9
MX - Messico 9
ID - Indonesia 8
JP - Giappone 8
IQ - Iraq 7
TR - Turchia 6
CO - Colombia 5
UA - Ucraina 5
IE - Irlanda 4
NG - Nigeria 4
PE - Perù 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BO - Bolivia 3
CH - Svizzera 3
EC - Ecuador 3
IL - Israele 3
PT - Portogallo 3
PY - Paraguay 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AQ - Antartide 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
CL - Cile 1
EG - Egitto 1
ET - Etiopia 1
GY - Guiana 1
IR - Iran 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
VE - Venezuela 1
Totale 2.593
Città #
Singapore 127
Ashburn 122
Moscow 102
Dallas 92
Hong Kong 74
San Jose 67
Shanghai 53
New York 38
Ho Chi Minh City 37
Beijing 32
Hefei 30
Lauterbourg 25
Hanoi 22
Lawrence 20
Los Angeles 20
Princeton 20
São Paulo 20
Boardman 18
Orem 17
Warsaw 15
Brooklyn 13
Milan 13
Frankfurt am Main 11
Montreal 11
Munich 10
Rome 9
Atlanta 8
Helsinki 8
Turku 8
Johannesburg 7
Santa Clara 7
Tokyo 7
Da Nang 6
Houston 6
Phoenix 6
Poplar 6
Pune 6
Toronto 6
Amsterdam 5
Brasília 5
Chennai 5
Denver 5
Mumbai 5
Paris 5
Rio de Janeiro 5
Stockholm 5
Dublin 4
Haiphong 4
Mexico City 4
Bilbao 3
Erbil 3
Falkenstein 3
Guangzhou 3
Hải Dương 3
Lima 3
Nuremberg 3
Rio Claro 3
San Francisco 3
Tashkent 3
The Dalles 3
Turin 3
Xi'an 3
Zurich 3
Alvin 2
Americana 2
Ankara 2
Asunción 2
Bady Bassitt 2
Baghdad 2
Baku 2
Bauru 2
Belo Horizonte 2
Boston 2
Bragança Paulista 2
Brescia 2
Buenos Aires 2
Campinas 2
Cesano Boscone 2
Cleveland 2
Cologne 2
Columbus 2
Contagem 2
Council Bluffs 2
Croydon 2
Cuiabá 2
Hanover 2
Holyhead 2
Honolulu 2
Lagos 2
Lappeenranta 2
Lari 2
Lisbon 2
London 2
Louveira 2
Manchester 2
Maricá 2
Montevideo 2
Muscat 2
Mushin 2
Palembang 2
Totale 1.267
Nome #
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 157
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 134
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 131
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 119
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 114
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation 110
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 108
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 107
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 103
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma 101
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 99
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 96
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 94
Comparison Between Urothelial and Non-Urothelial Urethral Cancer 88
Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidates 85
External beam radiation therapy improves survival in low-volume metastatic prostate cancer patients: a North American population-based study 81
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial 78
Improving the stratification of intermediate risk prostate cancer 77
Differences between rural and urban prostate cancer patients 74
Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma 73
Comparison between 1973 and 2004/2016 WHO grading systems in patients with Ta urothelial carcinoma of urinary bladder 73
Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients 71
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series 64
Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific Validation 60
Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer Patients 59
The effect of race/ethnicity on active treatment rates among septuagenarian or older low risk prostate cancer patients 59
The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer 57
The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy 56
The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patients 55
Re: Hiten D. Patel, Farzana A. Faisal, Bruce J. Trock, et al. Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial. Eur Urol 2020;78:360–368 50
Totale 2.633
Categoria #
all - tutte 12.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.966


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202222 0 2 1 12 0 0 1 0 2 1 0 3
2022/2023177 50 39 18 8 7 23 5 16 6 1 3 1
2023/2024183 3 12 14 20 17 38 1 39 0 6 8 25
2024/2025417 50 17 13 9 10 53 76 36 59 23 23 48
2025/20261.819 124 118 120 249 186 67 127 183 533 112 0 0
Totale 2.633